Author:
Doehmer Johannes,Goeptar Arnold R.,Vermeulen Nico P. E.
Reference26 articles.
1. Cholerton S, Daly AK, Idle JR (1992) The role of individual human cytochromes P450 in drug metabolism and clinical response. TiPS Reviews 13: 434–439.
2. Clarke L, Waxman DJ (1989) Oxidative metabolism of cyclophosphamide: identification of the hepatic mono-oxygenase catalysts of drug activation. Cancer Res 49: 2344–2350.
3. Doehmer J, Greim H (1993) Cytochromes P450 in genetically engineered cell cultures: the gene technological approach. In: Schenkman JB, Greim H (eds) Cytochrome P450. Heidelberg: Springer, 415–429.
4. Doehmer J, Seidel A, Oesch F, Glatt HR (1990) Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide. Env Health Persp 88: 63–65.
5. Fuhr U, Doehmer J, Battula N, Wölfel C, Kudla C, Keita Y, Staib AH (1992) Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Bioch Pharmacol 43: 225–235.